V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002655 | 10001743 | null | 86 | Palliative (P) | 2017-03-04 | 2017-03-04 | EOX | N | N | 10441211 | EOX |
| 10002656 | 10001744 | 1.77 | 85.8 | Palliative (P) | 2017-06-14 | 2017-06-14 | PEMBROLIZUMAB | N | N | 10441282 | PEMBROLIZUMAB |
| 10002657 | 10001745 | 1.72 | 58.4 | Palliative (P) | 2016-07-04 | 2016-07-04 | Gemcitabine weekly | 02 | N | 10441311 | GEMCITABINE |
| 10002658 | 10001746 | 1.75 | 67 | Palliative (P) | 2017-09-25 | 2017-10-16 | EOX | N | N | 10441312 | EOX |
| 10002659 | 10001747 | 1.59 | 60.1 | Disease modification (D) | 2017-08-27 | 2018-02-16 | Rituximab | N | N | 10441314 | RITUXIMAB |
| 10002660 | 10001748 | 1.69 | 79 | Palliative (P) | 2017-07-13 | 2017-08-01 | Cisplatin + Pemetrexed | N | N | 10441345 | CISPLATIN + PEMETREXED |
| 10002661 | 10001749 | 1.65 | 48 | Palliative (P) | null | 2015-10-11 | Carboplatin + Vinorelbine Oral | 2 | N | 10441349 | CARBOPLATIN + VINORELBINE |
| 10002662 | 10001749 | 1.6 | 42.9 | Curative (C) | 2015-08-18 | 2015-08-27 | EOX | N | N | 10441349 | EOX |
| 10002663 | 10001750 | 1.68 | 130 | Palliative (P) | 2015-12-14 | 2015-12-31 | GEMCITABINE | 02 | N | 10441354 | GEMCITABINE |
| 10002664 | 10001751 | null | 63.7 | Neo-adjuvant (N) | 2017-03-21 | 2017-03-24 | ECX | N | N | 10441362 | ECX |
| 10002665 | 10006245 | 1.54 | 0 | Palliative (P) | 2017-05-31 | 2017-06-14 | PEMBROLIZUMAB | N | N | 10441368 | PEMBROLIZUMAB |
| 10002666 | 10006245 | null | 0 | Palliative (P) | 2018-11-25 | 2018-11-28 | Enzalutamide | 2 | N | 10441368 | ENZALUTAMIDE |
| 10002667 | 10001752 | 1.7 | 74 | Adjuvant (A) | 2016-04-14 | 2016-04-28 | Cisplatin + Vinorelbine (IV) | N | N | 10441399 | CISPLATIN + VINORELBINE |
| 10002668 | 10001752 | 1.85 | 81 | Palliative (P) | 2015-08-25 | 2015-08-26 | Enzalutamide | 2 | N | 10441399 | ENZALUTAMIDE |
| 10002669 | 10001753 | 1.79 | 65.4 | Adjuvant (A) | 2014-07-21 | 2014-07-23 | Cisplatin + Vinorelbine (IV) | N | N | 10441548 | CISPLATIN + VINORELBINE |
| 10002670 | 10001754 | 1.85 | 100 | Palliative (P) | 2018-03-04 | 2018-03-11 | PEMBROLIZUMAB | 2 | N | 10441574 | PEMBROLIZUMAB |
| 10002671 | 10001754 | 1.6 | 50.8 | Palliative (P) | 2019-02-02 | 2019-02-02 | Cisplatin + Pemetrexed | N | N | 10441574 | CISPLATIN + PEMETREXED |
| 10002672 | 10001755 | null | 69.3 | null | 2015-06-01 | 2015-06-01 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 10441786 | GEMCITABINE |
| 10002673 | 10001755 | null | 65.4 | Palliative (P) | 2013-09-24 | 2013-09-28 | ECX | N | N | 10441786 | ECX |
| 10002674 | 10001756 | 1.77 | 61 | Palliative (P) | 2016-09-28 | 2016-11-10 | Cisplatin + Pemetrexed | 02 | N | 10441845 | CISPLATIN + PEMETREXED |
| 10002675 | 10001757 | 1.68 | 52 | Disease modification (D) | null | 2015-06-24 | Hydroxycarbamide | 02 | N | 10441846 | HYDROXYCARBAMIDE |
| 10002676 | 10001758 | null | 0 | Palliative (P) | 2016-07-07 | 2016-07-10 | Enzalutamide | Y | N | 10441907 | ENZALUTAMIDE |
| 10002677 | 10006249 | 1.74 | 81.9 | Palliative (P) | 2017-03-12 | 2017-03-26 | PEMBROLIZUMAB | 2 | N | 10441930 | PEMBROLIZUMAB |
| 10002678 | 10006249 | 0 | 79.2 | Palliative (P) | 2018-11-11 | 2018-11-14 | Enzalutamide | 2 | N | 10441930 | ENZALUTAMIDE |
| 10002679 | 10001759 | 1.82 | null | Palliative (P) | 2016-01-29 | 2016-02-12 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10441997 | GEMCITABINE |
| 10002680 | 10006250 | 1.59 | null | Curative (C) | 2018-04-18 | 2018-04-18 | Hydroxycarbamide | N | N | 10442021 | HYDROXYCARBAMIDE |
| 10002681 | 10006250 | null | 84.9 | Palliative (P) | 2019-03-15 | 2019-03-22 | EOX | null | N | 10442021 | EOX |
| 10002682 | 10001760 | 1.56 | null | Adjuvant (A) | 2018-01-10 | 2018-01-10 | Hydroxycarbamide | 02 | N | 10442109 | HYDROXYCARBAMIDE |
| 10002683 | 10001761 | null | 0 | Palliative (P) | 2017-10-27 | 2017-10-29 | Carboplatin + Vinorelbine Oral | 2 | N | 10442212 | CARBOPLATIN + VINORELBINE |
| 10002684 | 10001762 | 1.6 | 62 | Curative (C) | 2015-01-21 | 2015-02-03 | Cisplatin + Vinorelbine (IV) | 2 | N | 10442223 | CISPLATIN + VINORELBINE |
| 10002685 | 10006251 | 1.5 | 53.25 | Palliative (P) | 2017-12-29 | 2017-12-31 | EOX | N | N | 10442349 | EOX |
| 10002686 | 10001763 | 1.68 | 0 | Curative (C) | 2014-04-16 | 2014-05-08 | EOX | N | N | 10442377 | EOX |
| 10002687 | 10001763 | 1.76 | 76.3 | Palliative (P) | 2017-12-04 | 2017-12-04 | EOX | N | N | 10442377 | EOX |
| 10002688 | 10001763 | 1.71 | null | Curative (C) | 2017-12-25 | 2018-01-02 | Cisplatin + Vinorelbine (PO) | 02 | N | 10442377 | CISPLATIN + VINORELBINE |
| 10002689 | 10001764 | null | null | Palliative (P) | 2018-06-12 | 2018-06-12 | Cisplatin + Pemetrexed | N | N | 10442464 | CISPLATIN + PEMETREXED |
| 10002690 | 10001764 | null | 71 | Palliative (P) | 2018-08-31 | 2018-09-15 | Rituximab | null | N | 10442464 | RITUXIMAB |
| 10002691 | 10001765 | null | 0 | Palliative (P) | 2014-08-29 | 2014-08-30 | PEMBROLIZUMAB | N | N | 10442568 | PEMBROLIZUMAB |
| 10002692 | 10001766 | 1.63 | 48.8 | Adjuvant (A) | null | 2015-06-06 | Gemcitabine weekly | 02 | N | 10442652 | GEMCITABINE |
| 10002693 | 10001766 | null | 49.3 | Curative (C) | 2017-03-13 | 2017-03-23 | CVP R | N | null | 10442652 | CVP R |
| 10002694 | 10006255 | 1.67 | 87.2 | Adjuvant (A) | 2016-01-13 | 2016-01-15 | Cisplatin + Vinorelbine (IV) | 2 | N | 10442748 | CISPLATIN + VINORELBINE |
| 10002695 | 10001767 | 1.69 | 72.1 | Palliative (P) | 2013-09-27 | 2013-10-24 | ECX | 02 | N | 10442783 | ECX |
| 10002696 | 10001768 | 1.56 | 0 | null | 2016-03-13 | 2016-03-23 | Trial Unspecified | 02 | N | 10442842 | TRIAL |
| 10002697 | 10001769 | 0 | 81.5 | Palliative (P) | 2016-03-25 | 2016-03-25 | Trial Unspecified | Y | N | 10442894 | TRIAL |
| 10002698 | 10001770 | 1.8 | 80.9 | Palliative (P) | 2015-11-30 | 2015-12-04 | Hydroxycarbamide | N | N | 10442940 | HYDROXYCARBAMIDE |
| 10002699 | 10001771 | 1.84 | 109.4 | Palliative (P) | 2017-12-02 | 2017-12-14 | CVP R | N | N | 10443025 | CVP R |
| 10002700 | 10001772 | null | 83 | Palliative (P) | 2017-11-14 | 2017-11-23 | EOX | N | null | 10443042 | EOX |
| 10002701 | 10001773 | 1.71 | 60.6 | Adjuvant (A) | 2016-11-13 | 2016-12-04 | EOX | N | N | 10443192 | EOX |
| 10002702 | 10001773 | 1.79 | 86.4 | Palliative (P) | 2017-01-04 | 2017-01-11 | Cisplatin + Pemetrexed | N | N | 10443192 | CISPLATIN + PEMETREXED |
| 10002703 | 10001774 | 1.82 | 53.5 | null | 2017-08-15 | 2017-08-22 | CVP R | 02 | N | 10443306 | CVP R |
| 10002704 | 10001774 | 1.77 | 78.3 | Palliative (P) | 2017-06-15 | 2017-06-15 | Trial Unspecified | Y | N | 10443306 | TRIAL |